A multicenter, open-label, single-arm, phase Ib clinical trial of HH2853 treatment in patients with relapsed and/or refractory peripheral T-cell lymphoma
一项针对复发和/或难治性外周T细胞淋巴瘤患者的HH2853治疗的多中心、开放标签、单臂Ib期临床试验
期刊:Journal of Hematology & Oncology
影响因子:40.4
doi:10.1186/s13045-025-01697-z
Hong, Huangming; Chen, Zegeng; Zhang, Mingzhi; Peng, Zhigang; Shen, Jianzhen; Shuang, Yuerong; Zhou, Hui; Guo, Hongqiang; Huang, He; Li, Fei; Qian, Zhengzi; Liu, Lihong; Wang, Liang; Yang, Wei; Zhang, Liling; He, Pengcheng; Qian, Shen; Li, Fugen; Li, Meng; Lin, Tongyu